Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aquestive Therapeutics Inc (NQ: AQST )

4.060 -0.110 (-2.64%)
Streaming Delayed Price Updated: 12:26 PM EDT, Sep 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Aquestive Therapeutics Inc

< Previous 1 2 3 4 5 6 Next >
Aquestive Therapeutics to Participate in Three Investor Conferences in September
From GlobeNewswire News Releases
Aquestive Therapeutics Negotiates Six Month Extension to June 30, 2022 for Additional Libervant™ Related Capital Under Current Debt Agreement
From GlobeNewswire News Releases
Aquestive Therapeutics to Participate in 12th Annual Wedbush PacGrow Healthcare Virtual Conference
From GlobeNewswire News Releases
Aquestive Therapeutics Reports Second Quarter 2021 Financial Results, Provides Business Update and Raises Full Year Revenue Guidance
From GlobeNewswire News Releases
Aquestive Therapeutics to Report Second Quarter 2021 Financial Results and Recent Business Highlights on August 3 and Host Conference Call on August 4 at 8:00 a.m. ET
From GlobeNewswire News Releases
Aquestive Therapeutics Announces FDA Acceptance of New Drug Application (NDA) Resubmission for Libervant™ (diazepam) Buccal Film
From GlobeNewswire News Releases
Aquestive Therapeutics Resubmits New Drug Application for Libervant™ (diazepam) Buccal Film
From GlobeNewswire News Releases
SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)
From GlobeNewswire News Releases
Aquestive Therapeutics Announces Leadership Transition of Chief Financial Officer
From GlobeNewswire News Releases
Aquestive Therapeutics to Participate in JMP Securities and BMO Capital Market Investor Conferences
From GlobeNewswire News Releases
NASDAQ:AQST Long Term Investor Notice: Investigation over Possible Wrongdoing at Aquestive Therapeutics, Inc.
San Diego, CA -- (SBWIRE) -- 05/24/2021 -- Certain directors of Aquestive Therapeutics, Inc. are under investigation over possible breaches of fiduciary duties. 
From SBWire - Latest Press Releases
Aquestive Therapeutics to Participate in 2021 RBC Capital Markets Global Healthcare Conference
From GlobeNewswire News Releases
Aquestive Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
From GlobeNewswire News Releases
AQST Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Aquestive Therapeutics, Inc. Investors of Class Action and Lead Plaintiff Deadline: April 30, 2021
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aquestive Therapeutics, Inc. ("Aquestive" or "the Company") (NASDAQ: AQST)... 
From Business Wire News Releases
AQST IMPORTANT DEADLINE FRIDAY: ROSEN, A LEADING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important April 30 Deadline in Securities Class Action
From PR Newswire
Aquestive Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
From GlobeNewswire News Releases
AQST FINAL DEADLINE ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important April 30 Deadline in Securities Class
From GlobeNewswire News Releases
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aquestive Therapeutics, Inc. (AQST)
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aquestive Therapeutics, Inc. (AQST) 
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Pomerantz LLP is investigating claims on behalf of investors of Aquestive Therapeutics, Inc. ("Aquestive" or the "Company") (NASDAQ: AQST). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire
AQST Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Aquestive Therapeutics, Inc. Investors of Class Action and Lead Plaintiff Deadline: April 30, 2021
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aquestive Therapeutics, Inc. ("Aquestive" or "the Company") (NASDAQ: AQST)... 
From Business Wire News Releases
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm
Johnson Fistel, LLP, announces that class action lawsuits have commenced on behalf of shareholders of the publicly traded companies listed below. The Private Securities Litigation Reform Act of 1995... 
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
From GlobeNewswire News Releases
ROSEN, A LEADING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 30 Deadline in Securities Class Action – AQST
From GlobeNewswire News Releases
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aquestive Therapeutics, Inc. (AQST)
From GlobeNewswire News Releases
AQST ALERT: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. – AQST
From GlobeNewswire News Releases
MGI, AQST & VLDR Class Action Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
Aquestive Therapeutics to Report First Quarter 2021 Financial Results and Recent Business Highlights on May 4 and Host Conference Call on May 5 at 8:00 a.m. ET
From GlobeNewswire News Releases
NASDAQ:AQST Investor Notice: Deadline on April 30, 2021 in Lawsuit Against Aquestive Therapeutics, Inc.
San Diego, CA -- (SBWIRE) -- 04/20/2021 -- A deadline is coming up on April 30, 2021in the lawsuit filed for certain investors of Aquestive Therapeutics, Inc. (NASDAQ:AQST). 
From SBWire - Latest Press Releases
DEADLINE ALERT for UAVS, IQDAX, IQDNX, and AQST: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
Pomerantz LLP is investigating claims on behalf of investors of Aquestive Therapeutics, Inc. ("Aquestive" or the "Company") (NASDAQ: AQST). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.